Skip to main content

Advertisement

SpringerLink
Log in

Issues of Regret in Women With Contralateral Prophylactic Mastectomies

  • Original Article
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: Patients with a history of carcinoma of one breast have an estimated risk of 0.5% to 0.75% per year of developing a contralateral breast cancer. This risk prompts many women to consider contralateral prophylactic mastectomy (CPM) as a preventive measure. Virtually nothing is known about patient acceptance following CPM. We have developed a National Prophylactic Mastectomy Registry comprised of a volunteer population of 817 women from 43 states who have undergone prophylactic (unilateral or bilateral) mastectomy.

Methods: Of the 346 women with CPM who responded to national notices, 296 women returned detailed questionnaires. The information obtained included patient demographics, family history, reproductive history, ipsilateral breast cancer staging and treatment, as well as issues involving the CPM.

Results: At median follow-up of 4.9 years, the respondents were primarily married (79%), white (97%) women who had some level of college education or above (81%). These women cited the following reasons for choosing CPM: (1) physician advice regarding the high risk of developing contralateral breast cancer (30%); (2) fear of developing more breast cancer (14%); (3) desire for cosmetic symmetry (10%); (4) family history (7%); (5) fibrocystic breast disease (4%); (6) a combination of all of these reasons (32%); (7) other (2%); and (8) unknown (1%). Eighteen of the 296 women (6%) expressed regrets regarding their decision to undergo CPM. Unlike women with bilateral prophylactic mastectomies, regrets tended to be less common in the women with whom the discussion of CPM had been initiated by their physician (5%) than in the women who had initiated the discussion themselves (8%) (P = ns). Family history and stage of index lesion had no impact on regret status. The reasons for regret included: (1) poor cosmetic result, either of the CPM or of the reconstruction (39%); (2) diminished sense of sexuality (22%); (3) lack of education regarding alternative surveillance methods or CPM efficacy (22%); and (4) other reasons (17%).

Conclusions: To minimize the risk of regrets in women contemplating CPM, it is imperative that these women be counseled regarding an estimation of contralateral breast cancer risk, the alternatives to CPM, and the efficacy of CPM. In addition, these women should have realistic expectations of the cosmetic outcomes of surgery and understand the potential impact on their body image.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Hartman LC, Schaid DJ, Woods JE, et al. 1999; Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340:77–84

    Article  CAS  PubMed  Google Scholar 

  2. Hartmann L, Jenkins R, Schaid D, Yang P, et al. Prophylactic mastectomy: preliminary retrospective cohort analysis. Proc Am Assoc Cancer Res 1997;88:168.

    Google Scholar 

  3. Easton DF, Bishop DT, Ford D, Crockford GP, et al. Genetic linkage analysis in familial breast and ovarian cancer: results form 214 families. Am J Hum Genet 1993;52:678–701

    PubMed  CAS  Google Scholar 

  4. Easton DF, Ford D, Bishop DT, 1995; The Breast Cancer Linkage Consortium, et al. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56:265–71

    PubMed  CAS  Google Scholar 

  5. Ford D, Easton DF, Bishop DT, Narod SA, Goldar DE, 1994; the Breast Cancer Linkage Consortium, et al. Risks of cancer in BRCA1-mutation carriers. Lancet 343:692–5

    Article  PubMed  CAS  Google Scholar 

  6. Schrag D, Kuntz KM, Garber JE, Weeks JC, et al. Decision analysiseffects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 1997;336:1465–71

    Article  PubMed  CAS  Google Scholar 

  7. Grann VR, Panageas KS, Whang W, Antman KH, Neugut AI, et al. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive and BRCA2-positive patients. J Clin Oncol 1998;16:979–85

    PubMed  CAS  Google Scholar 

  8. Houn F, Helzsouer KJ, Friedman NB, Stefanek ME, et al. The practice of prophylactic mastectomy: A survey of Maryland surgeons. Am J Public Health 1995;85:801–5

    Article  PubMed  CAS  Google Scholar 

  9. Fisher ER, Fisher B, Sass R, Wickerham L, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol No 4). Cancer 1984;54:3002–11

    Article  PubMed  CAS  Google Scholar 

  10. Rosen PP, Groshen S, Kinne DW, Hellman S, et al. Contralateral breast carcinoma: an assessment of risk and prognosis in stage I and stage II patients with 20-year follow-up. Surgery 1989; 106:904–10

    PubMed  CAS  Google Scholar 

  11. Healey EA, Cook F, Schnitt SJ, Connolly JL, Harris JR, et al. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol 1993;11:1545–52

    PubMed  CAS  Google Scholar 

  12. Wanebo HJ, Senofsky GM, Fechner RE, Kaiser D, Lynn S, Paradies J, et al. Bilateral breast cancer: risk reduction by contralateral biopsy. Ann Surg 1985; 201:667–77

    Article  PubMed  CAS  Google Scholar 

  13. Simkovich AH, Sclafani LM, Masri M, Kinne DW, et al. Role of contralateral breast biopsy in infiltrating lobular cancer. Surgery 1993; 114:555–7

    PubMed  CAS  Google Scholar 

  14. Singletary SE, Taylor SH, Guinee VF, Whitworth PW, et al. Occurrence and prognosis of contralateral carcinoma of the breast. J Am Coll Surg 1994;178:390–6

    PubMed  CAS  Google Scholar 

  15. Robinson E, Rennert G, Rennert HS, Neugut AI, et al. Survival of first and second primary breast cancer. Cancer 1993; 71:172–6

    Article  PubMed  CAS  Google Scholar 

  16. Baker RR, Kuhajda FP, et al. The clinical management of a normal contralateral breast in patients with lobular breast cancer. Ann Surg 1989; 210:444–8

    Article  PubMed  CAS  Google Scholar 

  17. Smith BL, Bertagnolli M, Klein BB, Batter S, Chang M, Douville LM, Eberlein TJ, et al. Evaluation of the contralateral breast: the role of biopsy at the time of treatment of primary breast cancer. Ann Surg 1992; 216:17–21

    Article  PubMed  CAS  Google Scholar 

  18. Lee JSY, Grant CS, Donohue JH, Crotty TB, Harmsen WS, Ilstrup DM, et al. Arguments against routine contralateral mastectomy or undirected biopsy for invasive lobular breast cancer. Surgery 1995; 118: 640–8.

    Article  PubMed  CAS  Google Scholar 

  19. Mulvihill JJ, Safyer AW, Bening JK, et al. Prevention in familial breast cancer: counseling and prophylactic mastectomy. Prev Med 1982; 11:500–11

    Article  PubMed  CAS  Google Scholar 

  20. Borgen PI, Hill AD, Tran KN, VanZee KJ, Massie MJ, Payne D, Biggs CG, et al. Patient regrets after bilateral prophylactic mastectomy. Ann Surg Oncol 1998; 5:603–6

    Article  PubMed  CAS  Google Scholar 

  21. Cook LS, White E, Schwartz SM, McKnight B, Daling JR, Weiss NS, et al. A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States). Cancer Causes Control 1996; 7:382–90

    Article  PubMed  CAS  Google Scholar 

  22. Broet P, de la Rochefordiere A, Scholl SM, et al. 1995; Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol 13:1578–83

    PubMed  CAS  Google Scholar 

  23. Lopez MJ, Porter KA, et al. The current role of prophylactic mastectomy. Surg Clin North Am 1996;76:231–42

    Article  PubMed  CAS  Google Scholar 

  24. Ziegler LD, Kroll SS, et al. Primary breast cancer after prophylactic mastectomy. Am J Clin Oncol 1991;14:451–4

    PubMed  CAS  Google Scholar 

  25. Gershenwald JE, Hunt KK, Kroll SS, et al. Synchronous elective contralateral mastectomy and immediate bilateral breast reconstruction in women with early-stage breast cancer. Ann Surg Oncol 1998;5:529–38

    Article  PubMed  CAS  Google Scholar 

  26. Temple WJ, Lindsay RL, Magi E, Urbanski SJ, et al. Technical considerations for prophylactic mastectomy in patients at high risk for breast cancer. Am J Surg 1991;161:413–5

    Article  PubMed  CAS  Google Scholar 

  27. Calson GW, Grossl N, Lewis MM, Temple JR, Styblo TM. Preservation of the inframammary fold: what are we leaving behind? Plast Reconstr Surg 1996;98:447–50

    Article  Google Scholar 

  28. Sterns EE, Fletcher WA, et al. Bilateral cancer of the breast: a review of clinical, histologic and immunologic characteristics. Surgery 1991;110:617–22

    PubMed  CAS  Google Scholar 

  29. Harris RE, Lynch HT, Guirgis HA, et al. Familial breast cancer: risk to the contralateral breast. J Natl Cancer Inst 1978;60:955–60

    PubMed  CAS  Google Scholar 

  30. Slattery ML, Kerber RA, et al. A comprehensive evaluation of family history and breast cancer risk. The Utah population database. JAMA 1993;270:1563–8

    Article  CAS  PubMed  Google Scholar 

  31. Lesser ML, Rosen PP, Kinne DW, et al. Multicentricity and bilaterality in invasive breast carcinoma. Surgery 1982;91:234–40

    PubMed  CAS  Google Scholar 

  32. Robson M, Gilewski T, Haas B, et al. 1998; BRCA-associated breast cancer in young women. J Clin Oncol 16:1642–9

    PubMed  CAS  Google Scholar 

  33. Verhoog LC, Brekelmans CT, Seynaeve C, et al. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 1998;351:316–21

    Article  PubMed  CAS  Google Scholar 

  34. Yeatmen TJ, Lyman GH, Smith SK, Reintgen DS, Cantor AB, Cox CE, et al. Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment. Ann Surg Oncol 1997;4:198–202

    Article  Google Scholar 

  35. Chung MA, Cole B, Wanebo HJ, Bland KI, Chang HR, et al. Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol 1997;4:545–50

    Article  PubMed  CAS  Google Scholar 

  36. Cody HS. Routine contralateral breast biopsy: helpful or irrelevant? Ann Surg 1997;225:370–6

    Article  PubMed  Google Scholar 

  37. Habel LA, Moe RE, Daling JR, Holte S, Rossing MA, Weiss NS, et al. Risk of contralateral breast cancer among women with carcinoma in situ of the breast. Ann Surg 1997;225:69–75

    Article  PubMed  CAS  Google Scholar 

  38. Hancock SL, Tucker MA, Hoppe RT, et al. Breast cancer after treatment of Hodgkin’s disease. J Natl Cancer Inst 1993;85:25–31

    Article  PubMed  CAS  Google Scholar 

  39. Kroll SS, Miller MJ, Schusterman MA, Reece GP, Singletary SE, Ames F, et al. Rationale for elective contralateral mastectomy with immediate bilateral reconstruction. Ann Surg Oncol 1994;1:457–61

    Article  PubMed  CAS  Google Scholar 

  40. de la Rochefordiere A, Mouret-Fourme E, Asselain B, Scholl SM, Campana F, Broet P, Fourquet A, et al. Metachronous contralateral breast cancer as first event of relapse. Int J Radiat Oncol Biol Phys 1996;36:615–21

    PubMed  CAS  Google Scholar 

  41. Stefanek ME, Helzlsouer KJ, Wilcox PM, Houn F, et al. Predictors of and satisfaction with bilateral prophylactic mastectomy. Prev Med 1995;24:412–9

    Article  PubMed  CAS  Google Scholar 

  42. Lerman C, Daly M, Sands C, et al. 1993; Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 85:1074–80

    Article  PubMed  CAS  Google Scholar 

  43. Bostwick J. Preventive mastectomy. Ann Surg Oncol 1994;1:455–6

    Article  PubMed  Google Scholar 

  44. Early Breast Cancer Trialists’ Collaborative Group, et al. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998;351:1451–67

    Article  Google Scholar 

  45. Fisher B, Constantino J, Redmond C, et al. 1989;A randomized clinical trial evaluating tamoxifen in the treatment of patients with nodenegative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320:479–84

    Article  PubMed  CAS  Google Scholar 

  46. Ragaz J, Coldman A, et al. Survival impact of adjuvant tamoxifen on competing causes of mortality in breast cancer survivors, with analysis of mortality from contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic episodes. J Clin Oncol 1998;16:2018–24

    PubMed  CAS  Google Scholar 

  47. Garner B, et al. Prophylactic mastectomy: an unnecessary procedure. Ann Surg Oncol 1994;1:453–4

    Article  Google Scholar 

  48. Dean C, Chetty U, Forrest AP, et al. Effects of immediate breast reconstruction on psychosocial morbidity after mastectomy. Lancet 1983;1:459–62

    Article  PubMed  CAS  Google Scholar 

  49. Gabriel SE, Woods JE, O’Fallon WM, Beard CM, Kurland LT, Melton LJ, et al. Complications leading to surgery after breast implantation. N Engl J Med 1997;336:677–82

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York

    Leslie L. Montgomery MD, Katherine N. Tran BA, Melissa C. Heelan BA, Kimberly J. Van Zee MD, MS & Patrick I. Borgen MD

  2. Department of Psychiatry, Memorial Sloan-Kettering Cancer Center, New York, New York

    Mary Jane Massie MD & David K. Payne PhD

  3. Breast Service, Dept. of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY, 10021

    Leslie L. Montgomery MD

Authors
  1. Leslie L. Montgomery MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katherine N. Tran BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Melissa C. Heelan BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kimberly J. Van Zee MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mary Jane Massie MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. David K. Payne PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Patrick I. Borgen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leslie L. Montgomery MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Montgomery, L.L., Tran, K.N., Heelan, M.C. et al. Issues of Regret in Women With Contralateral Prophylactic Mastectomies. Ann Surg Oncol 6, 546–552 (1999). https://doi.org/10.1007/s10434-999-0542-1

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10434-999-0542-1

Key Words

Search

Navigation